A deep research company in the preclinical areas of cell differentiation and targeted therapy deployment methods. Leveraging Machine Learning and other data models with technology of CRISPR/CAS9 and TALENS.
MILES DEEP RESEARCH LLC.
A deep research company in the preclinical areas of cell differentiation and targeted therapy deployment methods. Leveraging Machine Learning and other data models with technology of CRISPR/CAS9 and TALENS.
We have a wide range of investor opportunities with a minimum investment of $150,000. Funding rounds are 2023 – 2025.
Joseph E. Miles, an entrepreneur based in Austin TX with decades of experience in insurance, technology and education industries. After close family diagnosis of Fallopian Tube and Non Small Cell Lung Cancer, Joseph began his cancer initiatives in 2013; with ramp ups in 2017 and the creation of Miles Deep Research LLC. in 2021. Combing the profitability models of the private sector, with research oriented staff and partnerships, Miles Deep Research will bring innovative products and solutions to the fields of oncology and pharmaceuticals.
Miles Deep Research (MDR) focuses on product development above all.